Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissionsJacalyn Rosenblatt, David Avigan, Richard M. Stone et al.|Science Translational Medicine|2016Cited by 165
Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host diseaseMyrna Nahas, Jacalyn Rosenblatt, Edwin P. Alyea et al.|Blood|2018Cited by 48
Cabozantinib is well tolerated in acute myeloid leukemia and effectively inhibits the resistance‐conferring FLT3/tyrosine kinase domain/F691 mutationAmir T. Fathi, Mark J. Levis, Traci M. Blonquist et al.|Cancer|2017Cited by 31
Phase II clinical trial evaluating Abatacept in patients with steroid-refractory chronic graft versus host diseaseAnita G. Koshy, Jacalyn Rosenblatt, Haesook T. Kim et al.|Blood|2023Cited by 16
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation Is Well Tolerated, Induces Anti-Tumor Immunity and May Lead to Eradication of Measureable DiseaseJacalyn Rosenblatt, David Avigan, Irit Avivi et al.|Blood|2015Cited by 12